Navigation Links
Global Genetic Testing Market Analysis

NEW YORK, Aug. 18, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Genetic Testing Market Analysis

In a rapidly growing molecular diagnostics market, genetic testing represents a highly attractive segment. Genetic testing is a form of medical test that recognizes alteration in chromosomes, genes, or proteins. Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Several hundred genetic tests are currently in use, and more are being developed.

With the significant increase in the number of available tests, the genetic testing market is witnessing a strong growth pattern. According to our latest report, "Global Genetic Testing Market Analysis", the global genetic testing sector was worth around US$ 1.5 Billion in 2010 that corresponds to a share of approximately 15% in the total molecular diagnostics market. The market is further likely to grow at the rate of around 26% during 2012-2015 to reach around US$ 4 Billion. Factors contributing to this growth include increasing demand of newborn screening, high incidences of Alzheimer disease, breast cancer, colorectal cancer, diabetes etc, and research innovations.

Controversies over the splendid growth of DTC genetic testing have attracted lots of opinions and views on the selling of DNA-based tests directly to consumers. With the FDA intervention, the subject has become of more significance and it would be interesting to see whether new regulations do come in or not. The report, in this context, has presented an effective insight on the current developments in DTC genetic tests.

The report "Global Genetic Testing Market Analysis", covers almost all aspects of the global genetic testing market and provides reliable statistics on current market size and other areas. The report focuses on key regions to illustrate the state of genetic testing market & developments as these countries are witnessing improved private sector activities. Moreover, the availability of gene tests for key diseases has been discussed in a prudent manner. Recent developments with respect to product launches and strategic acquisitions have also been covered. Overall, the report is meant to provide a worth insight into the genetic testing market that would help the client to get acquainted with all the necessary information.

1. Analyst View

2. Research Methodology

3. Introduction to Genetic Testing

4. Global Genetic Testing Market Overview

4.1 Market Outlook

4.2 DTC Genetic Testing

5. Disease Wise Analysis

5.1 Alzheimer's Disease

5.2 Cystic Fibrosis

5.3 Cancer

6. Country Level Analysis

6.1 US

6.2 Europe

6.3 Japan

6.4 Korea

7. Industry Developments

7.1 Key Product Launches

7.2 Key Strategic Acquisitions & Agreements

8. Regulatory Landscape

9. Competitive Assessment

9.1 Abbott Laboratories

9.2 Qiagen N.V.

9.3 bioMerieux SA

9.4 Hoffmann-La Roche Ltd

9.5 Quest Diagnostics

9.6 Myriad Genetics

List of Figures:

Figure 4-1: Molecular Diagnostics Market (Billion US$), 2008-2011

Figure 4-2: Genetic Testing Market (Billion US$), 2008-2011

Figure 4-3: Forecast for Molecular Diagnostics Market (Billion US$), 2012-2015

Figure 4-4: Forecast for Genetic Testing Market (Billion US$), 2012-2015

Figure 4-5: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)

Figure 4-6: Number of DTC Genetic Testing Companies by Country

Figure 6-1: Number of Laboratories and Diseases for Genetic Testing (1993-2010)

Figure 6-2: US - Share of Diagnostics Testing in Healthcare Spending

Figure 6-3: Europe - EQA Scheme Participation by Country (Number), 2010

Figure 9-1: Quest Diagnostics - Sales by Testing (%), 2010

Figure 9-2: Myriad Genetics - Sales by Products (%), 2011

List of Tables:

Table 4-1: Key Companies in DTC Genetic Testing Segment

Table 5-1: Test Availability and Market Size for Key Conditions (2008)

Table 6-1: US - FDA Approved Pharmacogenetic Tests

Table 6-2: EU - Key Indicators in Genetics Market

Table 6-3: Europe - Recognized Accreditation Bodies in Key Countries

Table 8-1: US - Key Elements for Genetic Testing Regulation

Table 8-2: EU - Genetic Testing Regulation in Key Countries

To order this report:

Genomics Industry: Global Genetic Testing Market Analysis

Genomics Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
2. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
3. Forward step in forecasting global warming
5. Bionovo to Present at Canaccord Adams Global Growth Conference
6. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
7. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
10. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
11. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... on December 29, 2015 at 11:00 a.m. Israel ... Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... of Eric Paneth and Izhak Tamir to the ... Rami Skaliter as external directors; , approval of an amendment to ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):